372 related articles for article (PubMed ID: 29934472)
1. Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells.
Porichis F; Hart MG; Massa A; Everett HL; Morou A; Richard J; Brassard N; Veillette M; Hassan M; Ly NL; Routy JP; Freeman GJ; Dubé M; Finzi A; Kaufmann DE
J Immunol; 2018 Aug; 201(3):971-981. PubMed ID: 29934472
[TBL] [Abstract][Full Text] [Related]
2. TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4
Duan S; Xu X; Wang J; Huang L; Peng J; Yu T; Zhou Y; Cheng K; Liu S
J Virol; 2021 Aug; 95(17):e0081621. PubMed ID: 34133900
[TBL] [Abstract][Full Text] [Related]
3. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
[TBL] [Abstract][Full Text] [Related]
4. Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions.
Porichis F; Hart MG; Zupkosky J; Barblu L; Kwon DS; McMullen A; Brennan T; Ahmed R; Freeman GJ; Kavanagh DG; Kaufmann DE
J Virol; 2014 Mar; 88(5):2508-18. PubMed ID: 24352453
[TBL] [Abstract][Full Text] [Related]
5. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
Papasavvas E; Azzoni L; Yin X; Liu Q; Joseph J; Mackiewicz A; Ross B; Lynn KM; Jacobson JM; Mounzer K; Kostman JR; Montaner LJ
J Viral Hepat; 2017 Oct; 24(10):865-876. PubMed ID: 28419653
[TBL] [Abstract][Full Text] [Related]
6. Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.
Teigler JE; Zelinskyy G; Eller MA; Bolton DL; Marovich M; Gordon AD; Alrubayyi A; Alter G; Robb ML; Martin JN; Deeks SG; Michael NL; Dittmer U; Streeck H
J Virol; 2017 Dec; 91(23):. PubMed ID: 28904197
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal
Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039
[TBL] [Abstract][Full Text] [Related]
8. CD4+ CD25+ regulatory T cells impair HIV-1-specific CD4 T cell responses by upregulating interleukin-10 production in monocytes.
Kwon DS; Angin M; Hongo T; Law KM; Johnson J; Porichis F; Hart MG; Pavlik DF; Tighe DP; Kavanagh DG; Streeck H; Addo MM; Kaufmann DE
J Virol; 2012 Jun; 86(12):6586-94. PubMed ID: 22496237
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T-cell help enhances NK cell function following therapeutic HIV-1 vaccination.
Jost S; Tomezsko PJ; Rands K; Toth I; Lichterfeld M; Gandhi RT; Altfeld M
J Virol; 2014 Aug; 88(15):8349-54. PubMed ID: 24829350
[TBL] [Abstract][Full Text] [Related]
10. IL-10
Jiang Y; Yang M; Sun X; Chen X; Ma M; Yin X; Qian S; Zhang Z; Fu Y; Liu J; Han X; Xu J; Shang H
BMC Infect Dis; 2018 Feb; 18(1):80. PubMed ID: 29439673
[TBL] [Abstract][Full Text] [Related]
11. Liver cirrhosis in HIV/HCV-coinfected individuals is related to NK cell dysfunction and exhaustion, but not to an impaired NK cell modulation by CD4
Polo ML; Ghiglione YA; Salido JP; Urioste A; Poblete G; Sisto AE; Martinez A; Rolón MJ; Ojeda DS; Cahn PE; Turk GJ; Laufer NL
J Int AIDS Soc; 2019 Sep; 22(9):e25375. PubMed ID: 31536177
[TBL] [Abstract][Full Text] [Related]
12. Increased Natural Killer Cell Activation in HIV-Infected Immunologic Non-Responders Correlates with CD4+ T Cell Recovery after Antiretroviral Therapy and Viral Suppression.
Luo Z; Li Z; Martin L; Hu Z; Wu H; Wan Z; Kilby M; Heath SL; Huang L; Jiang W
PLoS One; 2017; 12(1):e0167640. PubMed ID: 28076376
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cell counts in primary HIV infection predicts disease progression and immune restoration after treatment.
Wang Y; Zhang Y; Tang T; Zhao W; Fu S; Zhang Z; Fu Y; Xu J; Ding H; Han X; Jiang Y
Virology; 2020 Nov; 550():89-98. PubMed ID: 32920454
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy-induced dominant interleukin-2 HIV-1 Gag CD4+ T cell response: evidence of functional recovery of HIV-1-specific CD4+ T cells.
Tsalimalma K; Kordossis T; Choremi-Papadopoulou E
Scand J Immunol; 2011 Mar; 73(3):256-65. PubMed ID: 21204901
[TBL] [Abstract][Full Text] [Related]
15. Control of the HIV-1 DNA Reservoir Is Associated
Marras F; Casabianca A; Bozzano F; Ascierto ML; Orlandi C; Di Biagio A; Pontali E; Dentone C; Orofino G; Nicolini L; Taramasso L; Magnani M; Marincola FM; Wang E; Moretta L; De Maria A
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956765
[TBL] [Abstract][Full Text] [Related]
16. Interferon Alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8
Kwaa AKR; Talana CAG; Blankson JN
J Virol; 2019 Feb; 93(3):. PubMed ID: 30404799
[TBL] [Abstract][Full Text] [Related]
17. HIV-Infected Children Have Elevated Levels of PD-1+ Memory CD4 T Cells With Low Proliferative Capacity and High Inflammatory Cytokine Effector Functions.
Foldi J; Kozhaya L; McCarty B; Mwamzuka M; Marshed F; Ilmet T; Kilberg M; Kravietz A; Ahmed A; Borkowsky W; Unutmaz D; Khaitan A
J Infect Dis; 2017 Sep; 216(6):641-650. PubMed ID: 28934428
[TBL] [Abstract][Full Text] [Related]
18. Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity.
Azzoni L; Papasavvas E; Chehimi J; Kostman JR; Mounzer K; Ondercin J; Perussia B; Montaner LJ
J Immunol; 2002 Jun; 168(11):5764-70. PubMed ID: 12023377
[TBL] [Abstract][Full Text] [Related]
19. Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10.
Parato KG; Kumar A; Badley AD; Sanchez-Dardon JL; Chambers KA; Young CD; Lim WT; Kravcik S; Cameron DW; Angel JB
AIDS; 2002 Jun; 16(9):1251-6. PubMed ID: 12045490
[TBL] [Abstract][Full Text] [Related]
20. HIV mono-infection is associated with an impaired anti-hepatitis C virus activity of natural killer cells.
Goeser F; Glässner A; Kokordelis P; Wolter F; Lutz P; Kaczmarek DJ; Schwarze-Zander C; Boesecke C; Strassburg CP; Rockstroh JK; Spengler U; Krämer B; Nattermann J
AIDS; 2016 Jan; 30(3):355-63. PubMed ID: 26558728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
